Arovella Therapeutics Limited (ASX:ALA)
0.0770
-0.0010 (-1.28%)
At close: Mar 6, 2026
Arovella Therapeutics Market Cap
Arovella Therapeutics has a market cap or net worth of 92.95 million as of March 6, 2026. Its market cap has decreased by -55.21% in one year.
Market Cap
92.95M
Enterprise Value
73.59M
Revenue
3.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since January 24, 2002, Arovella Therapeutics's market cap has increased from 17.67M to 92.95M, an increase of 425.90%. That is a compound annual growth rate of 7.12%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LTR Pharma | 81.80M |
| Cynata Therapeutics | 80.73M |
| Paradigm Biopharmaceuticals | 112.01M |
| Alterity Therapeutics | 76.13M |
| Imugene | 75.56M |
| Radiopharm Theranostics | 74.43M |
| Island Pharmaceuticals | 123.80M |
| Botanix Pharmaceuticals | 126.43M |